DAWN
Price
$8.77
Change
-$0.72 (-7.59%)
Updated
Dec 1, 04:59 PM (EDT)
Capitalization
900.46M
98 days until earnings call
Intraday BUY SELL Signals
SLNO
Price
$49.01
Change
-$1.44 (-2.85%)
Updated
Dec 1, 04:59 PM (EDT)
Capitalization
2.63B
100 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DAWN vs SLNO

Header iconDAWN vs SLNO Comparison
Open Charts DAWN vs SLNOBanner chart's image
Day One Biopharmaceuticals
Price$8.77
Change-$0.72 (-7.59%)
Volume$42.38K
Capitalization900.46M
Soleno Therapeutics
Price$49.01
Change-$1.44 (-2.85%)
Volume$20.03K
Capitalization2.63B
DAWN vs SLNO Comparison Chart in %
DAWN
Daily Signal:
Gain/Loss:
SLNO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DAWN vs. SLNO commentary
Dec 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DAWN is a Hold and SLNO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 02, 2025
Stock price -- (DAWN: $9.49 vs. SLNO: $50.45)
Brand notoriety: DAWN and SLNO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DAWN: 42% vs. SLNO: 45%
Market capitalization -- DAWN: $900.46M vs. SLNO: $2.71B
DAWN [@Biotechnology] is valued at $900.46M. SLNO’s [@Biotechnology] market capitalization is $2.71B. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DAWN’s FA Score shows that 0 FA rating(s) are green whileSLNO’s FA Score has 0 green FA rating(s).

  • DAWN’s FA Score: 0 green, 5 red.
  • SLNO’s FA Score: 0 green, 5 red.
According to our system of comparison, DAWN is a better buy in the long-term than SLNO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DAWN’s TA Score shows that 5 TA indicator(s) are bullish while SLNO’s TA Score has 5 bullish TA indicator(s).

  • DAWN’s TA Score: 5 bullish, 4 bearish.
  • SLNO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, DAWN is a better buy in the short-term than SLNO.

Price Growth

DAWN (@Biotechnology) experienced а +11.38% price change this week, while SLNO (@Biotechnology) price change was +11.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.89%. For the same industry, the average monthly price growth was -0.60%, and the average quarterly price growth was +59.52%.

Reported Earning Dates

DAWN is expected to report earnings on Mar 09, 2026.

SLNO is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (+3.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLNO($2.63B) has a higher market cap than DAWN($900M). SLNO YTD gains are higher at: 12.236 vs. DAWN (-25.099). DAWN has higher annual earnings (EBITDA): -108.37M vs. SLNO (-176.1M). DAWN has more cash in the bank: 453M vs. SLNO (287M). DAWN has less debt than SLNO: DAWN (3M) vs SLNO (52.8M). DAWN has higher revenues than SLNO: DAWN (188M) vs SLNO (32.7M).
DAWNSLNODAWN / SLNO
Capitalization900M2.63B34%
EBITDA-108.37M-176.1M62%
Gain YTD-25.09912.236-205%
P/E RatioN/AN/A-
Revenue188M32.7M575%
Total Cash453M287M158%
Total Debt3M52.8M6%
FUNDAMENTALS RATINGS
SLNO: Fundamental Ratings
SLNO
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
66
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DAWNSLNO
RSI
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
85%
Momentum
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
83%
MACD
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 7 days ago
87%
Declines
ODDS (%)
Bearish Trend 12 days ago
81%
Bearish Trend 12 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
87%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
DAWN
Daily Signal:
Gain/Loss:
SLNO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTUCX58.380.30
+0.52%
Fidelity Advisor Telecommunications C
EQNBX24.020.10
+0.42%
MFS Equity Income B
MADCX29.780.12
+0.40%
BlackRock Emerging Mkts Instl
HSAFX9.90N/A
N/A
Hussman Strategic Allocation
DEMZX34.47-0.06
-0.17%
Nomura Emerging Markets R6

SLNO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLNO has been loosely correlated with BRNS. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SLNO jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNO
1D Price
Change %
SLNO100%
+1.82%
BRNS - SLNO
56%
Loosely correlated
+2.05%
BHVN - SLNO
41%
Loosely correlated
+5.80%
GRCE - SLNO
38%
Loosely correlated
-0.93%
SYRE - SLNO
35%
Loosely correlated
+0.84%
KROS - SLNO
35%
Loosely correlated
-0.11%
More